258 related articles for article (PubMed ID: 16816377)
1. Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice.
Simpson MA
Am J Pathol; 2006 Jul; 169(1):247-57. PubMed ID: 16816377
[TBL] [Abstract][Full Text] [Related]
2. Inducible hyaluronan production reveals differential effects on prostate tumor cell growth and tumor angiogenesis.
Bharadwaj AG; Rector K; Simpson MA
J Biol Chem; 2007 Jul; 282(28):20561-72. PubMed ID: 17502371
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing.
Bharadwaj AG; Kovar JL; Loughman E; Elowsky C; Oakley GG; Simpson MA
Am J Pathol; 2009 Mar; 174(3):1027-36. PubMed ID: 19218337
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice.
Simpson MA; Wilson CM; McCarthy JB
Am J Pathol; 2002 Sep; 161(3):849-57. PubMed ID: 12213713
[TBL] [Abstract][Full Text] [Related]
5. HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor.
Lokeshwar VB; Cerwinka WH; Isoyama T; Lokeshwar BL
Cancer Res; 2005 Sep; 65(17):7782-9. PubMed ID: 16140946
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells.
Liu N; Gao F; Han Z; Xu X; Underhill CB; Zhang L
Cancer Res; 2001 Jul; 61(13):5207-14. PubMed ID: 11431361
[TBL] [Abstract][Full Text] [Related]
7. Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors.
Jacobson A; Rahmanian M; Rubin K; Heldin P
Int J Cancer; 2002 Nov; 102(3):212-9. PubMed ID: 12397638
[TBL] [Abstract][Full Text] [Related]
8. Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells.
Simpson MA; Wilson CM; Furcht LT; Spicer AP; Oegema TR; McCarthy JB
J Biol Chem; 2002 Mar; 277(12):10050-7. PubMed ID: 11790779
[TBL] [Abstract][Full Text] [Related]
9. Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors.
Rizzardi AE; Vogel RI; Koopmeiners JS; Forster CL; Marston LO; Rosener NK; Akentieva N; Price MA; Metzger GJ; Warlick CA; Henriksen JC; Turley EA; McCarthy JB; Schmechel SC
Cancer; 2014 Jun; 120(12):1800-9. PubMed ID: 24668563
[TBL] [Abstract][Full Text] [Related]
10. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells.
Li Y; Li L; Brown TJ; Heldin P
Int J Cancer; 2007 Jun; 120(12):2557-67. PubMed ID: 17315194
[TBL] [Abstract][Full Text] [Related]
11. HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion.
Lokeshwar VB; Cerwinka WH; Lokeshwar BL
Cancer Res; 2005 Mar; 65(6):2243-50. PubMed ID: 15781637
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer.
Posey JT; Soloway MS; Ekici S; Sofer M; Civantos F; Duncan RC; Lokeshwar VB
Cancer Res; 2003 May; 63(10):2638-44. PubMed ID: 12750291
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan synthase 2 overexpression is correlated with the tumorigenesis and metastasis of human breast cancer.
Li P; Xiang T; Li H; Li Q; Yang B; Huang J; Zhang X; Shi Y; Tan J; Ren G
Int J Clin Exp Pathol; 2015; 8(10):12101-14. PubMed ID: 26722395
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan mediates adhesion of metastatic colon carcinoma cells.
Laurich C; Wheeler MA; Iida J; Neudauer CL; McCarthy JB; Bullard KM
J Surg Res; 2004 Nov; 122(1):70-4. PubMed ID: 15522317
[TBL] [Abstract][Full Text] [Related]
15. Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity.
Kosaki R; Watanabe K; Yamaguchi Y
Cancer Res; 1999 Mar; 59(5):1141-5. PubMed ID: 10070975
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronidase 1 and hyaluronidase 2 are required for renal hyaluronan turnover.
Colombaro V; Jadot I; Declèves AE; Voisin V; Giordano L; Habsch I; Flamion B; Caron N
Acta Histochem; 2015 Jan; 117(1):83-91. PubMed ID: 25468725
[TBL] [Abstract][Full Text] [Related]
17. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer.
Lokeshwar VB; Rubinowicz D; Schroeder GL; Forgacs E; Minna JD; Block NL; Nadji M; Lokeshwar BL
J Biol Chem; 2001 Apr; 276(15):11922-32. PubMed ID: 11278412
[TBL] [Abstract][Full Text] [Related]
18. Role of HYAL1 expression in primary breast cancer in the formation of brain metastases.
Witzel I; Marx AK; Müller V; Wikman H; Matschke J; Schumacher U; Stürken C; Prehm P; Laakmann E; Schmalfeldt B; Milde-Langosch K; Oliveira-Ferrer L
Breast Cancer Res Treat; 2017 Apr; 162(3):427-438. PubMed ID: 28168629
[TBL] [Abstract][Full Text] [Related]
19. Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane.
Saito T; Kawana H; Azuma K; Toyoda A; Fujita H; Kitagawa M; Harigaya K
Int J Oncol; 2011 Nov; 39(5):1311-20. PubMed ID: 21743962
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of hyaluronan, HAS1-2, and HYAL1-2 in oral lichen planus.
Siponen M; Kullaa A; Nieminen P; Salo T; Pasonen-Seppänen S
J Oral Pathol Med; 2015 Jul; 44(6):401-9. PubMed ID: 25421996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
